Thyroid cancer has shown a parallel increase with diabetes in the last few years. This
narrative review aims to explain the association between these two entities, focusing on …

Context Whether radioactive iodine therapy (RAIT) is necessary for intermediate-risk
papillary thyroid cancer (PTC) after total thyroidectomy is still lacking reliable evidence …

Simple Summary No clinical studies have investigated the effect of radioiodine (131I)-
targeted therapy on the potential markers of ongoing inflammation in patients with DTC …

Objectives To explore the association between diabetes and outcomes in thyroidectomy
patients. Methods This retrospective cohort analysis used the 2015–2017 American College …

Background The effect of remnant-cholesterol (remnant-C) on incident end-stage renal
disease (ESRD) has not been studied longitudinally. This retrospective cohort study …

Simple Summary The cardiovascular effects of radioiodine (131I) therapy on people with
differentiated thyroid cancer (DTC) and concomitant type 2 diabetes mellitus (T2DM) are …

Background We investigated the association between exercise habits before or after
thyroidectomy and incident type 2 diabetes mellitus (T2DM) in patients with thyroid cancer …

Objective. To investigate the relationship between changes in blood glucose and blood lipid
levels and the risk of thyroid cancer in patients with type 2 diabetes mellitus. Methods. A total …

Objective This study aimed to assess the risk of cardiometabolic disease (CMD) in patients
with differentiated thyroid cancer (DTC) using a population-based nationwide cohort in …

Thyroidectomy is the gold standard in treating cancer thyroid patients. Thyroidectomy
patients are more susceptible to type 2 diabetes mellitus (T2DM) development. T2DM is a …